Happel David sold SGMT
February 10, 2026 · Form 4 insider transaction
Happel David sold 12,101 shares of Sagimet Biosciences Inc. at $5.36 per share, a transaction worth $64.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
12,101
Price
$5.36
Total value
$64.9K
InsiderHappel David
RoleOfficer, Director
SecuritySeries A Common Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 10, 2026
Filing dateFebruary 12, 2026
Shares owned after677,621
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.